October 05, 2026 12:13 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Asian Games 2026: India beat Pakistan to clinch gold in men's cricket | flydubai cockpit attack: Deleted posts expose Omani co-pilot’s views on women, alleged extremist past | flydubai cockpit horror: Omani co-pilot Hamam al-Hammami attacked Captain Smit Machchhar with crash axe, tried to seize control | flydubai temporarily suspends all Israel flights after co-pilot’s alleged cockpit attack, crash attempt | Grounded in Oman over ‘radical views’, then hired by flydubai: What we know about Omani pilot Hamam al-Hammami | ‘Hanuman Chalisa gave me courage’: Smit Machchhar recounts flydubai cockpit battle to PM Modi | PM Modi speaks to Flydubai pilot Smit Machchhar who foiled crash plot, praises his courage | Putin praises Modi’s ‘good ideas’ to end Ukraine war, thanks Indian PM for peace efforts | Flydubai cockpit attack: Injured Indian pilot Smit Machchhar airlifted to Abu Dhabi | India backs brave flydubai pilot Smit Machchhar, Ambassador meets family after cockpit attack
UK | COVID booster vaccine

UK approves COVID-19 booster vaccine for people over 40 years

| @indiablooms | Nov 16, 2021, at 01:32 am

London/UNI/Sputnik: The United Kingdom’s Joint Committee on Vaccination and Immunisation (JCVI) on Monday announced that people over 40 years old living in the country will now be eligible to receive a booster COVID-19 vaccine six months after having their second dose, as a new study showed that boosters give over 90 percent protection in adults over 50.

“JCVI has previously advised booster vaccination for all adults aged 50 years and over and those in a Covid-19 at-risk group. The offer has now been broadened to include those aged 40 to 49 years,” the committee said in a statement.

The booster vaccines to be offered to this new age group are Pfizer-BioNTech and Moderna, the same mRNA-type vaccine that has been used since September in people over 50 and at higher risk from the coronavirus SARS-CoV-2.

So far, more than 12,6 million people in the UK have had the third dose.

According to a study released on Monday by the UK Health Security Agency, two weeks after receiving a booster dose, protection against symptomatic infection in adults aged 50 years and over was 93.1 percent in those who first had AstraZeneca as their primary vaccine and 94.0 percent for Pfizer-BioNTech.

The JCVI also advised that all 16- to 17-year-olds who are not in an at-risk group should be offered a second dose of the Pfizer vaccine 12 weeks or more following the first vaccine dose.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.